Shenzhen FRD Science - Public Comps and Valuation Multiples

Shenzhen FRD Science Overview

About Shenzhen FRD Science

Shenzhen FRD Science & Techonology Co Ltd is a China based company engaged in manufacturing of EMI shielding materials, Thermal interface materials and other related electronic materials. The company has a business presence in China, and other countries. EMI shielding materials include metal shielding products, electrically conductive elastomer, fabric over foam and conductive, electrically conductive plastics, and microwave absorber. Thermal materials comprise graphite film, thermal interface material, and thermally conductive plastics. The other supporting materials offered by the entity are PUR hot melt adhesive, and graphics overlay and labels.

Founded

2008

HQ

Employees

n/a

Website

frd.cn

Sectors

Electronic Components
Advanced Materials
DeepTech

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$1.5B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Shenzhen FRD Science Financials

Shenzhen FRD Science has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Shenzhen FRD Science achieved revenue of $599M and an EBITDA of $52.1M.

Shenzhen FRD Science expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Shenzhen FRD Science valuation multiples based on analyst estimates

Shenzhen FRD Science P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$599M	n/a	XXX	XXX	XXX
Gross Profit	$66.2M	$98.4M	XXX	XXX	XXX
Gross Margin	11%	NaN%	XXX	XXX	XXX
EBITDA	$52.1M	n/a	XXX	XXX	XXX
EBITDA Margin	9%	NaN%	XXX	XXX	XXX
Net Profit	$4.1M	$13.3M	XXX	XXX	XXX
Net Margin	1%	NaN%	XXX	XXX	XXX
Net Debt	$37.9M	$137M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Shenzhen FRD Science Stock Performance

As of April 15, 2025, Shenzhen FRD Science's stock price is CNY 19 (or $3).

Shenzhen FRD Science has current market cap of CNY 11.0B (or $1.5B), and EV of CNY 11.1B (or $1.5B).

See Shenzhen FRD Science trading valuation data

Shenzhen FRD Science Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.5B	$1.5B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Shenzhen FRD Science Valuation Multiples

As of April 15, 2025, Shenzhen FRD Science has market cap of $1.5B and EV of $1.5B.

Shenzhen FRD Science's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Shenzhen FRD Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Shenzhen FRD Science and 10K+ public comps

Shenzhen FRD Science Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$1.5B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	XXX	XXX
P/E	n/a	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Shenzhen FRD Science Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Shenzhen FRD Science Valuation Multiples

Shenzhen FRD Science's NTM/LTM revenue growth is n/a

Shenzhen FRD Science's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Shenzhen FRD Science's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Shenzhen FRD Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Shenzhen FRD Science and other 10K+ public comps

Shenzhen FRD Science Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	n/a	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	1%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	2%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	5%	XXX	XXX	XXX	XXX
Opex to Revenue	14%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry